Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

TAZ Inhibitors

Transcriptional co-activator with PDZ-binding motif, commonly referred to as TAZ, is a multifunctional protein that holds a pivotal role in cellular signaling pathways and transcriptional regulation. TAZ is part of the Hippo signaling pathway, a highly conserved pathway essential for controlling organ size, tissue growth, and cellular differentiation. This protein functions as a transcriptional co-activator, meaning it does not directly bind to DNA but instead associates with other transcription factors to modulate gene expression. TAZ is particularly known for its involvement in processes related to cell proliferation, stem cell maintenance, and tissue regeneration.

Structurally, TAZ possesses a PDZ-binding motif at its carboxy-terminal end, which allows it to interact with various protein partners. Its activity is highly regulated by post-translational modifications, including phosphorylation, which determine its subcellular localization and interaction with transcription factors. TAZ is predominantly localized in the cell nucleus when active, where it can promote the transcription of genes involved in cell growth and differentiation. Its versatility in influencing gene expression makes TAZ a critical player in the fine-tuning of cellular responses to various environmental cues and developmental signals. TAZ inhibitors constitute a chemical class of compounds designed to specifically target and modulate the activity of the TAZ protein. These inhibitors are typically small molecules that interact with TAZ, disrupting its ability to engage with transcription factors or other co-activators. By interfering with TAZ's transcriptional co-activator functions, these compounds can influence cell fate decisions, including stem cell differentiation, and impact various cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Verteporfin

129497-78-5sc-475698
sc-475698A
10 mg
100 mg
$347.00
$2710.00
5
(0)

Verteporfin disrupts the interaction between TAZ and TEAD transcription factors, inhibiting the transcriptional output of TAZ.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Dasatinib, primarily a tyrosine kinase inhibitor, has been shown to decrease TAZ protein levels, potentially through off-target effects.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine, a broad-spectrum kinase inhibitor, might affect the phosphorylation and stability of TAZ.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin has been shown to reduce TAZ expression, potentially through its effects on transcription or protein stability.

Calpeptin

117591-20-5sc-202516
sc-202516A
10 mg
50 mg
$119.00
$447.00
28
(1)

Rho signaling can activate TAZ. By inhibiting Rho, this compound might suppress TAZ activation and function.

FK-506

104987-11-3sc-24649
sc-24649A
5 mg
10 mg
$76.00
$148.00
9
(1)

Tacrolimus has been reported to decrease TAZ protein levels in certain contexts, potentially affecting its transcriptional activity.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide inhibits protein synthesis, which can lead to reduced TAZ protein levels.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$65.00
$210.00
26
(2)

2-DG, a glucose analog, can affect various metabolic pathways and has been shown to decrease TAZ expression.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

Geldanamycin induces the degradation of Hsp90 client proteins. It might affect TAZ stability and promote its degradation.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Y-27632 is a ROCK inhibitor. ROCK can influence TAZ activity, so its inhibition might down-regulate TAZ function.